Physician

Amruta Surendra Jaju

According to 2025 Medicare claims, Amruta Jaju (NPI: 1205171709) practices endocrinology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is NOVANT HEALTH MEDICAL GROUP, LLC (NPI: 1588386296; TIN: 581728803) and primary practice location at 28277-3147. Jaju is affiliated with the Novant Health Accountable Care Organization I, LLC (ACO ID: A3504), participating under the MSSP model.

Jaju's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 207 traditional Medicare patients, billed 1,241 HCPCS/CPT codes, and received $47,825 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,134 prescription claims across 312 beneficiaries totaling $1,753,288 in drug costs, led by Ozempic (Semaglutide). DME data shows 459 claims. Open Payments data shows 4 records totaling $91. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $23,243 and ending at $47,825. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $294,138 to $1,753,288. For DME billing, reported payments moved sharply higher in recent years, from $873 to $104,678.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	186	398	$23,243
2016	163	566	$31,232
2017	149	631	$32,364
2018	137	619	$36,195
2019	93	164	$10,838
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	102	394	$18,314
2023	159	1,092	$42,967
2024	207	1,241	$47,825

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	283	3,362	$294,138
2016	208	3,056	$252,297
2017	195	3,423	$213,243
2018	180	3,326	$237,568
2019	179	1,529	$182,227
2020	112	397	$131,534
2021	51	190	$68,029
2022	161	596	$434,304
2023	286	2,973	$2,083,948
2024	312	3,134	$1,753,288

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	15	38	$684
2016	15	65	$680
2017	11	95	$1,230
2018	12	108	$872
2019	N/R	78	$425
2020	N/R	16	$188
2021	N/R	N/R	N/R
2022	14	39	$7,177
2023	107	453	$84,738
2024	69	459	$108,916

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	83	83	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	145	297	$83
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	133	198	$12
83036	Hemoglobin a1c level	85	161	$10
36415	Insertion of needle into vein for collection of blood sample	114	168	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	331	12,708	$409,454
Mounjaro	Tirzepatide	332	10,538	$382,305
Jardiance	Empagliflozin	237	11,890	$231,173
Tresiba Flextouch U-200	Insulin Degludec	98	5,789	$92,465
Trulicity	Dulaglutide	50	1,794	$61,333

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	51	392	$97,687
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	18	$7,573
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	12	$2,847
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	18	37	$809

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$91	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amruta Surendra Jaju?

Tedicare shows public-source Medicare data for Amruta Surendra Jaju (NPI 1205171709), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amruta Surendra Jaju have ACO affiliation data?

Amruta Surendra Jaju is shown with ACO affiliation data for Novant Health Accountable Care Organization I, LLC (MSSP, ACO ID A3504).

What billing organization is linked to Amruta Surendra Jaju?

Amruta Surendra Jaju is linked to NOVANT HEALTH MEDICAL GROUP, LLC (billing NPI 1588386296) in the available physician profile data.

Does Amruta Surendra Jaju have Open Payments data?

Amruta Surendra Jaju has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.